Trial intelligence / Profile preview

Pilocarpine vs Artificial Tears for Dry Eye Disease

NCT06752278Completed

Sponsor
Al-Azhar University
Start
Oct 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of pilocarpine in dry eye disease (DED) (2 arms), sponsored by Al-Azhar University. Primary endpoints: Ocular Surface Disease Index at 6 weeks and Tear Film Break-Up Time at 6 weeks. Started Oct 2024; status: completed.

02

Drugs

pilocarpine
03

Conditions

dry eye disease (DED)

Beyond the preview

Go deeper on NCT06752278.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06752278.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call